Hansoh Pharmaceutical Group Company Limited Share Price OTC Markets
Equities
HNSPF
KYG549581067
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | +19.75% | -.--% | +2.73% |
30/04 | Hansoh Pharmaceutical’s 2023 Profit Up 27% | MT |
29/04 | Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024 | CI |
Sales 2024 * | 11.82B 1.63B 136B | Sales 2025 * | 12.49B 1.72B 144B | Capitalization | 89.34B 12.32B 1,027B |
---|---|---|---|---|---|
Net income 2024 * | 3.74B 516M 43B | Net income 2025 * | 3.81B 525M 43.77B | EV / Sales 2024 * | 5.76 x |
Net cash position 2024 * | 21.23B 2.93B 244B | Net cash position 2025 * | 23.86B 3.29B 274B | EV / Sales 2025 * | 5.24 x |
P/E ratio 2024 * |
23.5
x | P/E ratio 2025 * |
23.3
x | Employees | 9,123 |
Yield 2024 * |
1.02% | Yield 2025 * |
1.06% | Free-Float | 18.24% |
1 day | +19.75% | ||
3 months | +19.75% | ||
6 months | +2.73% | ||
Current year | +2.73% |
Managers | Title | Age | Since |
---|---|---|---|
Hui Juan Zhong
CEO | Chief Executive Officer | 63 | 02/15/02 |
Sheng Li Zhong
SEC | Corporate Secretary | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Qiang Lin
BRD | Director/Board Member | 81 | 31/19/31 |
Sheung Wai Chan
BRD | Director/Board Member | 70 | 14/19/14 |
Dong Tao Yang
BRD | Director/Board Member | 67 | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.84% | 727B | |
+30.57% | 592B | |
-7.66% | 347B | |
+15.54% | 319B | |
-0.30% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-2.94% | 160B |
- Stock Market
- Equities
- 3692 Stock
- HNSPF Stock